Results for tag: "Argininosuccinic Aciduria Drug"

Argininosuccinic Aciduria (ASA) is a rare genetic disorder that affects the body's ability to break down proteins. Hematological drugs are used to treat ASA, as they help to reduce the amount of ammonia in the blood. These drugs work by inhibiting the enzyme argininosuccinate synthetase, which is responsible for the production of argininosuccinic acid. Hematological drugs can also help to reduce the risk of complications associated with ASA, such as liver and kidney damage. The Argininosuccinic Aciduria Drug market is composed of a variety of companies that specialize in the development and production of drugs to treat ASA. These companies include Sanofi, Pfizer, Novartis, and Merck, among others. These companies are focused on developing new treatments and improving existing treatments for ASA, in order to provide better outcomes for patients. Show Less Read more